نتایج جستجو برای: her2 antigen

تعداد نتایج: 214094  

Background: In addition to passive immunotherapy using anti-HER2 monoclonal antibodies, active immunotherapy via HER2 targeting is an interesting approach to inducing specific anti-tumor immune responses. We have recently reported the immunogenicity of HER2 subdomains following DNA immunization and HER2 protein boosting. In the present study, we evaluated the immunogenicity of different HER2 ex...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Linda C Benavides Jeremy D Gates Mark G Carmichael Ritesh Patil Jarrod P Holmes Matthew T Hueman Elizabeth A Mittendorf Dianna Craig Alexander Stojadinovic Sathibalan Ponniah George E Peoples

PURPOSE HER2/neu, a source of immunogenic peptides, is expressed in >75% of breast cancer patients. We have conducted clinical trials with the HER2/neu E75 peptide vaccine in breast cancer patients with varying levels of HER2/neu expression. Vaccine response based on HER2/neu expression level was analyzed. EXPERIMENTAL DESIGN Patients were stratified by HER2/neu expression. Low expressors (n ...

Journal: :Molecular cancer therapeutics 2006
Gustavo Helguera José A Rodríguez Manuel L Penichet

We have previously generated antihuman HER2/neu-humanized IgG3 fused to interleukin-2 (IL-2), IL-12, or granulocyte macrophage colony-stimulating factor (GM-CSF) [monofunctional fusion proteins (mono-AbFP)] or fused to IL-2 and IL-12 or IL-12 and GM-CSF [bifunctional fusion proteins (bi-AbFP)]. These AbFPs retained cytokine and antigen-binding activities. We have now further characterized the A...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه تربیت مدرس - دانشکده علوم پزشکی 1393

مقدمه و هدف: سرطان فرآیندی پیچیده و چند مرحله¬ای است که با تغییرات سلولی مختلف همراه است؛ سرطان سینه، پنجمین عامل شایع مرگ و میر در سراسر دنیاست و در بین زنان شایع ترین سرطان کشنده است. عوامل محیطی و ژنتیکی متفاوتی در ایجاد سرطان سینه دخالت دارند. یکی از دلایل شناخته شده جهش در ژن her2 است. هدف این مطالعه کلونینگ ژن گیرنده her2 در وکتور بیانی +pcdna3.1 hygro و بیان این وکتور نوترکیب در سلول های...

2016

Abbreviations: APC: Antigen-Presenting Cell; DCs: Dendritic Cells; RECIST: Response Evaluation Criteria in Solid Tumors; HLA: Human Leukocyte Antigen; MDSCs: Myeloid-Derived Suppressor Cells; CTLs: Cytotoxic T Cells; GM-CSF: Granulocyte-Macrophage ColonyStimulating Factor; TGF: Transforming Growth Factor; IL: Interleukin ; VEGF: Vascular Endothelial Growth Factor; PGE2: Prostaglandin E2; PD-L1:...

احمدوند, داوود, رحیمی جمنانی, فاطمه, رهبری‌زاده, فاطمه, شکرگزار, محمد علی, مهبودی, فریدون,

  چکید ه   سابقه و هدف   ریزش مارکرهای سرطانی مانند HER2 از سطح سلول‌های سرطانی سینه، باعث مخفی ماندن آن‌ها از دید سلول‌های ایمنی می‌گردد. افزایش غلظت HER2 محلول( sHER2 )، در نتیجه درمان سرطان سینه HER2+ و پاسخ به تراستوزومب، تاثیرگذار است. در همین راستا، آنتی‌بادی‌های تک دومینی شتری( VHH ) به علت خصوصیات منحصر به فرد و توانایی بالا در شناسایی آنتی‌ژن، مواد هدفمند بسیار مؤثری در شناسایی sHER2 م...

2011
Jenny Bostrom Lauric Haber Patrick Koenig Robert F. Kelley Germaine Fuh

The antigen-binding site of Herceptin, an anti-human Epidermal Growth Factor Receptor 2 (HER2) antibody, was engineered to add a second specificity toward Vascular Endothelial Growth Factor (VEGF) to create a high affinity two-in-one antibody bH1. Crystal structures of bH1 in complex with either antigen showed that, in comparison to Herceptin, this antibody exhibited greater conformational vari...

2014
Ana Textor Joanna J. Listopad Cynthia Perez Anna Kruschinski Markus Chmielewski Hinrich Abken Thomas Blankenstein Jehad Charo

Adoptive T-cell therapy using chimeric antigen receptor–modified T cells (CAR-T therapy) has shown dramatic efficacy in patients with circulating lymphoma. However, eradication of solid tumors with CAR-T therapy has not been reported yet to be efficacious. In solid tumors, stroma destruction, due to MHC-restricted cross-presentation of tumor antigens to T cells, may be essential. However, CAR-T...

Journal: :Cancer research 2014
Ana Textor Joanna J Listopad Lara Le Wührmann Cynthia Perez Anna Kruschinski Markus Chmielewski Hinrich Abken Thomas Blankenstein Jehad Charo

Adoptive T-cell therapy using chimeric antigen receptor-modified T cells (CAR-T therapy) has shown dramatic efficacy in patients with circulating lymphoma. However, eradication of solid tumors with CAR-T therapy has not been reported yet to be efficacious. In solid tumors, stroma destruction, due to MHC-restricted cross-presentation of tumor antigens to T cells, may be essential. However, CAR-T...

Journal: :Cancers 2021

Correlative studies of clinical for hematological malignancies have implicated that less differentiated, CD8+-dominant CAR T cell products greater antitumor activity. Here, we investigated whether the differentiation status affects their activity in preclinical models solid tumors. We explored if different activation/expansion protocols, as well co-stimulatory domains construct, influence short...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید